Bio Essence Corporation (BIOE)
| Market Cap | 25.29M +868.5% |
| Revenue (ttm) | 2.91M +416.6% |
| Net Income | 1.52M |
| EPS | 0.03 |
| Shares Out | 53.81M |
| PE Ratio | 13.77 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Open | 0.4700 |
| Previous Close | 0.4400 |
| Day's Range | 0.4700 - 0.4700 |
| 52-Week Range | 0.0510 - 0.5170 |
| Beta | 10.87 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About Bio Essence
Bio Essence Corporation engages in manufacturing and distributing health supplement products. It also offers original equipment manufacturing, and private label services for dietary supplements, vitamins, and herbal nutrition products. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California. [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
Bio Essence Corporation Expands MediFlow Platform with Development of Practitioner-Specific AI and RAG Technology
New development initiative is designed to add practitioner-specific AI, secure knowledge management and retrieval-augmented generation capabilities to MediFlow. IRVINE, CA / ACCESS Newswire / October ...
Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio
Global AI in Fitness and Wellness Market Size was valued at USD 10.68 Billion in 2025 and is predicted to reach USD 57.80 Billion by the year 2035 at a 19.3% CAGR during the forecast period for 2026 t...
BIO ESSENCE CORP (OTCQB:BIOE) Announces Approval for Upgrade to the OTCQB Market, Effective February 26, 2026
The company's approval to upgrade to the OTCQB Venture Market underscores a growing trend among international, growth-stage companies to expand U.S. investor access and enhance market liquidity. The O...